Aerobic Growth of Anaerobic Pathogens
厌氧病原体的需氧生长
基本信息
- 批准号:8416323
- 负责人:
- 金额:$ 20.63万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2012
- 资助国家:美国
- 起止时间:2012-02-01 至 2014-07-31
- 项目状态:已结题
- 来源:
- 关键词:AbscessAcuteAddressAerobicAirAllelesAnaerobic BacteriaAnaerobiosisAnimal Disease ModelsAnimal ModelAnimalsAntibiotic TherapyAntibioticsBacteriaBacteroides fragilisBiochemicalBiologicalBiological AssayCellsCharacteristicsClinicalClostridium difficileColonCoupledDNA ResequencingDiarrheaDisadvantagedDiseaseEnvironmentEnzymesEpidemicExposure toExtravasationGene Expression ProfileGenesGenomeGram-Negative BacteriaGram-Positive BacteriaGreater sac of peritoneumGrowthHabitatsHamstersHydrogen PeroxideIn VitroInfectionIntestinesLarge IntestineMapsModelingMusMutagenesisMutateMutationNADHNADPOxidantsOxygenParentsPathogenesisPathway interactionsPeritonealPeroxidasesPhenotypePhysiologicalPopulationProteinsProtocols documentationPseudomembranous ColitisReactive Oxygen SpeciesRoleSiteStressSulfhydryl CompoundsTestingTextbooksThioredoxinVirulenceWorkbasecell typeelectron donorena proteingenome sequencingmembermutantnovelnull mutationpathogenpathogenic bacteriaplanetary Atmospherepreventprotein functiontransmission process
项目摘要
DESCRIPTION (provided by applicant): Two very different bacterial pathogens, the Gram-negative Bacteroides fragilis and the Gram-positive Clostridium difficile, have been considered as textbook examples of strict anaerobes that inhabit the large intestine. B. fragilis is a normal inhabitant of the colon, but C. difficile is usually found in people whose normal microbiota has been compromised by antibiotic treatment. B. fragilis is an opportunistic pathogen mainly associated with escape from the intestine due to leakage into and formation of abscesses in the peritoneal cavity. C. difficile, on the other hand, is the primary cause of antibiotic-associated diarrhea and pseudomembranous colitis. Given that the normal habitat for these bacteria is the anaerobic environment of the large intestine, it is remarkable that our preliminary results have shown that mutants of B. fragilis and C. difficile arise that can grow in the presence of oxygen (up to 2%) and can survive exposure to even higher oxygen levels. Many of these mutants have oxe (oxygen-enabling) null mutations that lie in a gene called oxeA that is conserved in the two otherwise very dissimilar species. Moreover, many clinical isolates of B. fragilis derived from abscesses can grow in 1.5% oxygen and have oxeA mutations as well. This application seeks to explain these unexpected findings by addressing a fundamental biological question: Why do anaerobic pathogens normally express genes whose products prevent them from growing aerobically? Our working hypothesis is that the wild-type product(s) of the oxe genes promote growth or survival in the anaerobic colon whereas the oxe mutations enhance some aspects of pathogenesis in animal hosts. To test this hypothesis we will compare the colonization, virulence and transmission of B. fragilis and C. difficile wild-type and oxe mutant strains in animal models of disease. In addition, we will seek to uncover the biochemical mechanisms by which the oxe gene products prevent survival and growth in low levels of oxygen. The results are expected to reveal a novel and surprising aspect of anaerobic growth.
描述(由申请人提供):两种截然不同的细菌病原体,革兰氏阴性菌化菌Fragilis和革兰氏阳性艰难梭菌,被认为是严格吞咽的教科书示例,居住在大肠中。 B. fragilis是结肠的正常居民,但艰难梭菌通常在抗生素治疗损害的正常微生物群中发现。 B. fragilis是一种机会性病原体,主要与腹膜腔中脓肿的渗漏和形成,主要与逃离肠道逃脱有关。另一方面,艰难梭菌是抗生素相关腹泻和假膜结肠炎的主要原因。鉴于这些细菌的正常栖息地是大肠的厌氧环境,值得注意的是,我们的初步结果表明,在氧气(最高2%)的情况下会出现脆弱的和艰难梭菌的突变体,并且可以在暴露于更高氧气水平的情况下生存。这些突变体中的许多具有牛(增强氧)的无效突变,该突变位于一个称为Oxea的基因中,该基因在两个原本不同的物种中是保守的。此外,源自脓肿的脆弱芽孢杆菌的许多临床分离株也可以在1.5%的氧气中生长,并且也具有氧气突变。该应用程序试图通过解决一个基本的生物学问题来解释这些意外的发现:为什么厌氧病原体通常表达其产物阻止其有氧生长的基因?我们的工作假设是OXE基因的野生型产物促进了厌氧结肠中的生长或存活,而OXE突变则增强了动物宿主发病机理的某些方面。为了检验这一假设,我们将比较疾病动物模型中Fragilis和艰难梭菌野生型和Oxe突变体菌株的定殖,毒力和传播。此外,我们将寻求揭示OXE基因产物阻止氧气生存和生长的生化机制。结果预计将揭示出厌氧生长的新颖而令人惊讶的方面。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
MICHAEL H MALAMY其他文献
MICHAEL H MALAMY的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('MICHAEL H MALAMY', 18)}}的其他基金
GENETIC SYSTEMS TO STUDY VIRULENCE IN B FRAGILIS
研究脆弱拟杆菌毒力的遗传系统
- 批准号:
2060940 - 财政年份:1983
- 资助金额:
$ 20.63万 - 项目类别:
GENETIC SYSTEMS TO STUDY VIRULENCE BACTEROIDES FRAGILES
研究脆性拟杆菌毒力的遗传系统
- 批准号:
3128849 - 财政年份:1983
- 资助金额:
$ 20.63万 - 项目类别:
GENETIC SYSTEMS TO STUDY VIRULENCE BACTEROIDES FRAGILES
研究脆性拟杆菌毒力的遗传系统
- 批准号:
3128855 - 财政年份:1983
- 资助金额:
$ 20.63万 - 项目类别:
GENETIC SYSTEMS TO STUDY VIRULENCE IN BACTEROIDES
研究拟杆菌毒力的遗传系统
- 批准号:
2611175 - 财政年份:1983
- 资助金额:
$ 20.63万 - 项目类别:
Genetic Systems to Study Virulence in Bacteroides
研究拟杆菌毒力的遗传系统
- 批准号:
6889578 - 财政年份:1983
- 资助金额:
$ 20.63万 - 项目类别:
GENETIC SYSTEMS TO STUDY VIRULENCE IN B FRAGILIS
研究脆弱拟杆菌毒力的遗传系统
- 批准号:
2060939 - 财政年份:1983
- 资助金额:
$ 20.63万 - 项目类别:
GENETIC SYSTEMS TO STUDY VIRULENCE IN BACTEROIDES
研究拟杆菌毒力的遗传系统
- 批准号:
3128854 - 财政年份:1983
- 资助金额:
$ 20.63万 - 项目类别:
GENETIC SYSTEMS TO STUDY VIRULENCE IN BACTEROIDES
研究拟杆菌毒力的遗传系统
- 批准号:
3128853 - 财政年份:1983
- 资助金额:
$ 20.63万 - 项目类别:
GENETIC SYSTEMS TO STUDY VIRULENCE IN BACTEROIDES
研究拟杆菌毒力的遗传系统
- 批准号:
2886423 - 财政年份:1983
- 资助金额:
$ 20.63万 - 项目类别:
相似国自然基金
阿魏酸基天然抗氧化抗炎纳米药物用于急性肾损伤诊疗一体化研究
- 批准号:82302281
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
SGO2/MAD2互作调控肝祖细胞的细胞周期再进入影响急性肝衰竭肝再生的机制研究
- 批准号:82300697
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于hemin-MOFs的急性心肌梗塞标志物负背景光电化学-比色双模分析
- 批准号:22304039
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
RNA甲基转移酶NSUN2介导SCD1 mRNA m5C修饰调控急性髓系白血病细胞铁死亡的机制研究
- 批准号:82300173
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于IRF5/MYD88信号通路调控巨噬细胞M1极化探讨针刀刺营治疗急性扁桃体炎的机制研究
- 批准号:82360957
- 批准年份:2023
- 资助金额:30 万元
- 项目类别:地区科学基金项目
相似海外基金
Development of clinically translatable MRI methodologies for the thoracic spinal cord
胸脊髓临床可转化 MRI 方法的开发
- 批准号:
10728689 - 财政年份:2023
- 资助金额:
$ 20.63万 - 项目类别:
Inhaled tigecycline therapy for pulmonary M. abscessus infections
吸入替加环素治疗肺部脓肿分枝杆菌感染
- 批准号:
10312329 - 财政年份:2021
- 资助金额:
$ 20.63万 - 项目类别:
Inhaled tigecycline therapy for pulmonary M. abscessus infections
吸入替加环素治疗肺部脓肿分枝杆菌感染
- 批准号:
10437923 - 财政年份:2021
- 资助金额:
$ 20.63万 - 项目类别:
Retention and Re-Engagement in Treatment for Addiction following Serious Injection Related Infections (RETAIN)
严重注射相关感染后保留和重新参与成瘾治疗(RETAIN)
- 批准号:
10282857 - 财政年份:2021
- 资助金额:
$ 20.63万 - 项目类别:
Retention and Re-Engagement in Treatment for Addiction following Serious Injection Related Infections (RETAIN)
严重注射相关感染后保留和重新参与成瘾治疗(RETAIN)
- 批准号:
10428651 - 财政年份:2021
- 资助金额:
$ 20.63万 - 项目类别: